Evaluation of inflammatory mediators in the deciduas of pregnant women with pre-eclampsia/eclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 1, 2016, Pages 75-79

  Peixoto, Alberto Borges ^a,b   Araujo, Edward ^c   Ribeiro, João Ulisses ^a   Rodrigues, Denise Bertulucci Rocha ^a,b   Castro, Eumênia Costa Cunha ^a   Caldas, Taciana Mara Rodrigues Cunha ^a   Rodrigues, Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b UNIVERSITY OF UBERABA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Eclampsia; Hypoxia; Nitric oxide; Pre eclampsia; Trophoblast

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; NITRATE; NITRIC OXIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; ECLAMPSIA; FEMALE; HUMAN; HUMAN TISSUE; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; ADOLESCENT; CASE CONTROL STUDY; MATERNAL HYPERTENSION; METABOLISM; PREGNANCY; TH1 TH2 BALANCE; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DECIDUA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INTERLEUKINS; NITRITES; PREGNANCY; TH1-TH2 BALANCE; YOUNG ADULT;

EID: 84948694664     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2014.987117     Document Type: Article

References (22)

1. Levine RJ, Hauth JC, Curet LB, et al. Trial calcium to prevent pre-eclampsia. N Engl J Med 1997; 337: 69-76.
2. Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014; 121: 14-24.
3. Report of the National High Blood Pressure Education. Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183: S1-22.
4. Parra M, Rodrigo R, Barja P, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486-91.
5. Pijnenborg R. The placental bed. Hypertens Pregnancy 1996; 15: 7-23.
6. Zhou Y, Fisher SJ, Janatpour M, et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99: 2139-51.
7. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003; 69: 1-7.
8. Christopher WG, Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
9. Readman CW, Sargent IL. Lasted advances in understanding preeclampsia. Science 2005; 308: 1592-4.
10. Hayashi M, Ueda Y, Yamaguchi T, et al. Tumor necrosis factor-alpha in the placenta is not elevated in preeclamptic patients despite its elevation in peripheral blood. Am J Reprod Immunol 2005; 53: 113-19.
11. Kupferminc MJ, Pearceman AM, Wigton TR, et al. Tumor necrosis factor-α is elevated in plasma and amniotic fluid patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752-7.
12. Yoshizumi M, Perrella MA, Burnett JC, Lee MET. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shorting its half-life. Circ Res 1993; 73: 205-9.
13. Teixeira-Salum TB, Rodrigues DB, Gervásio AM, et al. Distinct Th1, Th2 and Treg cytokines balance in chronic periapical granulomas and radicular cysts. J Oral Pathol Med 2010; 39: 250-6.
14. Pizano AL, Zamudio JL, Ortega VF, et al. The predominant Th1 cytokine profile in maternal plasma of preeclamptic women is not reflected in the choriodecidual and fetal compartments. J Soc Gynecol Investig 2005; 12: 335-42.
15. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interations in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-6.
16. Benyo DF, Samarason A, Redman CW, et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505-12.
17. Hung TH, Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-α from human placental tissues induced by hypoxia-reoxigenation causes endothelial cell activation in vitro. Am J Pathol 2004; 164: 1049-61.
18. Munno I, Chiechi LM, Lacedra G, et al. Spontaneous and induced release of prostaglandins, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor alfa by placental tissue from normal and preeclamptic pregnancies. Am J Reprod Immunol 1999; 42: 369-74.
19. Banerjee S, Smallwood A, Moorhead J, et al. Placental expression of Interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab 2005; 90: 944-52.
20. Shaamash AH, Elsonosy ED, Zakhari MM, et al. Placental nitric oxide synthase (NOS) activity and nitric oxide (NO) production in normal pregnancy, preeclampsia and eclampsia. Int J Gynecol Obstet 2001; 72: 127-33.
21. Norris LA, Higgins JR, Darling MR, et al. Nitric oxide in the uteroplacental, fetoplacental and peripheral circulations in pre-eclampsia. Obstet Gynecol 1999; 93: 958-63.
22. Kim YJ, Park HS, Lee HY, et al. Reduced l-arginine level and decreased placental eNOS activity in preeclampsia. Placenta 2006; 27: 438-44.